Target intelligence / Profile preview

Bone Mineral Matrix (Bone Matrix)

Target
Bone Matrix
Molecular classification
Extracellular matrix, Composite material, Structural component
01

Overview

The bone mineral matrix is the extracellular component of bone tissue, responsible for its strength, rigidity, and mineral storage capacity. It is a composite material consisting of organic components (primarily type I collagen and non-collagenous proteins) and inorganic components (mainly hydroxyapatite crystals). The matrix provides mechanical support, protects vital organs, serves as a mineral reservoir, and facilitates movement. Its formation and remodeling are tightly regulated by osteoblasts and osteoclasts, and disruptions in these processes can lead to various bone diseases.

Other names
Bone matrixExtracellular bone matrixOsseous matrix
02

Mechanism of action

Bisphosphonates: Inhibit osteoclast-mediated bone resorption. Denosumab: Inhibits RANKL, reducing osteoclast formation and activity. SERMs: Estrogen agonists/antagonists that modulate bone remodeling. Teriparatide: Stimulates bone formation by promoting osteoblast activity. Calcium/Vitamin D: Provide building blocks for bone mineralization. Fluoride: Stimulates osteoblast activity, increasing bone mass (but may affect bone quality).

03

Biological functions

Mechanical supportMineral storage (calcium, phosphate)Organ protectionAttachment site for musclesRegulation of osteoblast and osteoclast activityHematopoiesis support (indirectly)
04

Disease associations

OsteoporosisOsteomalaciaRicketsPaget's diseaseBone fracturesOsteogenesis imperfectaSkeletal dysplasiaBone cancer (metastasis and primary tumors)
05

Safety considerations

Bisphosphonates: Osteonecrosis of the jaw, atypical femur fractures.Denosumab: Hypocalcemia, increased risk of infections.Fluoride: Fluorosis (skeletal and dental), increased fracture risk at high doses.
06

Interacting drugs

Bisphosphonates

6 more in the full profile.

07

Biomarkers

Bone-specific alkaline phosphatase (ALP)OsteocalcinC-telopeptides (CTX)N-telopeptides (NTX)Procollagen type I N-terminal propeptide (P1NP)

Beyond the preview

Go deeper on Bone Mineral Matrix (Bone Matrix).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bone Mineral Matrix (Bone Matrix).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call